IJCCR_2024v14n2

International Journal of Clinical Case Reports 2024, Vol.14, No.2, 66-78 http://medscipublisher.com/index.php/ijccr 75 diagnostic and therapeutic functions (Landry and Tabor, 2017). The ability to deploy such bacteria in vivo, with considerations for sensor detection thresholds, circuit computation speed, and evolutionary stability, represents a significant advancement in the field (Landry and Tabor, 2017). Overall, the future of SynCom engineering for gut health is promising, with emerging trends and technologies paving the way for more personalized, effective, and sustainable probiotic therapies. Continued research and innovation in this field will likely lead to significant breakthroughs that improve human health and well-being. 8 Concluding Remarks Engineered probiotics can be designed to deliver therapeutics and respond to environmental cues within the gut, showing promise in treating diseases like inflammatory bowel disease and metabolic disorders. However, current synthetic probiotics often lack the complexity and adaptability of native gut microbiota, necessitating advanced synthetic biology tools to enhance their functionality. Furthermore, the survival and effectiveness of engineered probiotics are significantly influenced by dietary factors, such as the intake of vitamin B1, which affects the gut microbial community's composition and functionality. The integration of AI and synthetic biology has accelerated the development of probiotics with diagnostic and therapeutic capabilities, facilitating personalized medicine approaches. For researchers, the findings call for the development of more complex and adaptable synthetic probiotics that can mimic the native gut microbiota. Emphasis should be placed on interdisciplinary collaboration to advance synthetic biology tools and methodologies. Healthcare providers should be aware of the new avenues engineered probiotics offer for non-invasive treatment options for various gastrointestinal and metabolic disorders, staying informed about advancements in probiotic therapies to provide cutting-edge treatments. For policymakers, there is a need to update regulatory frameworks to address the safety and efficacy of synthetic probiotics, supporting research and development in this field while ensuring public health safety. To advance the field of synthetic microbial communities and their applications in gut health, further research is needed in several areas. Understanding the complex interactions within synthetic microbial communities to design more effective probiotics is essential. Leveraging AI and computational models to predict probiotic behavior and optimize their design for better health outcomes is another critical area of focus. Conducting rigorous clinical trials to evaluate the safety, efficacy, and long-term effects of synthetic probiotics in diverse populations is necessary. Additionally, addressing the ethical implications and establishing robust regulatory guidelines to ensure the safe use of engineered probiotics are crucial steps. In conclusion, engineering synthetic microbial communities holds great promise for enhancing probiotic functionality and improving gut health. Continued interdisciplinary research and collaboration are essential to overcome current challenges and realize the full potential of these innovative therapies. Acknowledgments The author would like to thank the anonymous peer reviewers for their insightful and constructive feedback, which has enriched and improved the content of this study. Conflict of Interest Disclosure The author affirms that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References Arcidiacono S., Spangler J., Litteral V., Doherty L., Stamps B., Walper S., Goodson M., and Soares J., 2023, In Vitro fermentation evaluation of engineered sense and respond probiotics in polymicrobial communities, ACS Biomaterials Science & Engizneering, 9(9): 5176-5185. https://doi.org/10.1021/acsbiomaterials.3c00630 Baldi S., Mundula T., Nannini G., and Amedei A., 2021, Microbiota shaping - the effects of probiotics, prebiotics, and fecal microbiota transplant on cognitive functions: a systematic review, World Journal of Gastroenterology, 27(39): 6715-6732. https://doi.org/10.3748/wjg.v27.i39.6715

RkJQdWJsaXNoZXIy MjQ4ODYzNQ==